$KOPN
KOPIN CORP

2024 Q4 Form 10-Q Financial Statement

#000149315224044738 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $206.0K
YoY Change -74.22%
Cost Of Revenue $8.317M
YoY Change 45.99%
Gross Profit $5.003M
YoY Change 5.04%
Gross Profit Margin 2428.69%
Selling, General & Admin $5.207M
YoY Change -19.47%
% of Gross Profit 104.08%
Research & Development $2.597M
YoY Change -17.1%
% of Gross Profit 51.9%
Depreciation & Amortization $138.5K
YoY Change -15.16%
% of Gross Profit 2.77%
Operating Expenses $16.12M
YoY Change 5.39%
Operating Profit -$2.801M
YoY Change -42.08%
Interest Expense -$540.7K
YoY Change -83.82%
% of Operating Profit
Other Income/Expense, Net -$534.5K
YoY Change -83.83%
Pretax Income -$3.335M
YoY Change -59.03%
Income Tax $125.0K
% Of Pretax Income
Net Earnings -$3.460M
YoY Change -57.7%
Net Earnings / Revenue -1679.91%
Basic Earnings Per Share -$0.03
Diluted Earnings Per Share -$0.03
COMMON SHARES
Basic Shares Outstanding 158.8M shares 121.0M shares
Diluted Shares Outstanding 124.3M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.24M
YoY Change 41.19%
Cash & Equivalents $14.53M
Short-Term Investments $21.71M
Other Short-Term Assets $2.697M
YoY Change 28.8%
Inventory $6.555M
Prepaid Expenses
Receivables $9.234M
Other Receivables $0.00
Total Short-Term Assets $63.00M
YoY Change 37.2%
LONG-TERM ASSETS
Property, Plant & Equipment $2.016M
YoY Change 12.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.129M
YoY Change -32.35%
Other Assets $124.9K
YoY Change -26.14%
Total Long-Term Assets $7.576M
YoY Change -19.77%
TOTAL ASSETS
Total Short-Term Assets $63.00M
Total Long-Term Assets $7.576M
Total Assets $70.58M
YoY Change 27.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.386M
YoY Change -32.6%
Accrued Expenses $13.69M
YoY Change 110.13%
Deferred Revenue $268.5K
YoY Change -51.62%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $43.95M
YoY Change 194.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $1.619M
YoY Change 16.42%
Total Long-Term Liabilities $1.619M
YoY Change 16.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $43.95M
Total Long-Term Liabilities $1.619M
Total Liabilities $47.85M
YoY Change 146.18%
SHAREHOLDERS EQUITY
Retained Earnings -$400.1M
YoY Change 14.57%
Common Stock $1.533M
YoY Change 38.85%
Preferred Stock
YoY Change
Treasury Stock (at cost) $103.2K
YoY Change 0.05%
Treasury Stock Shares
Shareholders Equity $22.73M
YoY Change
Total Liabilities & Shareholders Equity $70.58M
YoY Change 27.48%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$3.460M
YoY Change -57.7%
Depreciation, Depletion And Amortization $138.5K
YoY Change -15.16%
Cash From Operating Activities -$6.457M
YoY Change 69.13%
INVESTING ACTIVITIES
Capital Expenditures $10.27K
YoY Change -92.34%
Acquisitions
YoY Change
Other Investing Activities -$14.24M
YoY Change -360.62%
Cash From Investing Activities -$14.25M
YoY Change -367.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 25.20M
YoY Change
NET CHANGE
Cash From Operating Activities -6.457M
Cash From Investing Activities -14.25M
Cash From Financing Activities 25.20M
Net Change In Cash 4.486M
YoY Change 196.31%
FREE CASH FLOW
Cash From Operating Activities -$6.457M
Capital Expenditures $10.27K
Free Cash Flow -$6.467M
YoY Change 63.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-19882
dei Entity Registrant Name
EntityRegistrantName
KOPIN CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2833935
dei Entity Address Address Line1
EntityAddressAddressLine1
125 North Drive
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01581-3335
dei City Area Code
CityAreaCode
(508)
dei Local Phone Number
LocalPhoneNumber
870-5959
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
dei Trading Symbol
TradingSymbol
KOPN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14530593 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1050000 usd
CY2024Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
21712243 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9233935 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8274538 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
6555359 usd
CY2024Q3 us-gaap Prepaid Taxes
PrepaidTaxes
84885 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1561710 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
63003263 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2305433 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124925 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
3129434 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4385635 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1724776 usd
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2675000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
268468 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
653546 usd
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
227500 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1971681 usd
CY2024Q3 us-gaap Deposits
Deposits
102481 usd
CY2024Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
470884 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
dei Entity Central Index Key
EntityCentralIndexKey
0000771266
CY2023Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
usd
CY2023Q3 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
usd
dei Document Type
DocumentType
10-Q
dei Entity Address City Or Town
EntityAddressCityOrTown
Westborough
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.01
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
158800600 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
500000 usd
CY2023Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
11692000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1015000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9706036 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3409809 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7601806 usd
CY2023Q4 us-gaap Prepaid Taxes
PrepaidTaxes
85572 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1124635 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
39830543 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2016452 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2163417 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2504909 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
124925 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
4688522 usd
CY2023Q4 us-gaap Assets
Assets
49312316 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4947338 usd
CY2023Q4 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1701506 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2160000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
916826 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
790000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1702681 usd
CY2023Q4 us-gaap Deposits
Deposits
408156 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
470884 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6666717 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2129421 usd
CY2024Q3 us-gaap Litigation Reserve Current
LitigationReserveCurrent
24800000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
43946688 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
15878315 usd
CY2024Q3 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
372903 usd
CY2023Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
278112 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1634390 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1832982 usd
CY2024Q3 KOPN Accrued Postretirement Benefits Net Of Current Portion
AccruedPostretirementBenefitsNetOfCurrentPortion
279996 usd
CY2023Q4 KOPN Accrued Postretirement Benefits Net Of Current Portion
AccruedPostretirementBenefitsNetOfCurrentPortion
319996 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1619016 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1494016 usd
CY2024Q3 us-gaap Liabilities
Liabilities
47852993 usd
CY2023Q4 us-gaap Liabilities
Liabilities
19803421 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
158769894 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
114253818 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
153182916 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
112251416 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1532589 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
420066150 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
385411542 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
76064 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
70635 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
103127 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1316545 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1232294 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-400085589 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-358155034 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
22726514 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
29508895 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70579507 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49312316 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13319608 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10598497 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35688672 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31816544 usd
CY2024Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
8316904 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
5437953 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
25543806 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
17759117 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2596649 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3089935 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6537065 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8534411 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5206880 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4798598 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19706613 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15912848 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
24800000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
16120433 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
13326486 usd
us-gaap Operating Expenses
OperatingExpenses
76587484 usd
us-gaap Operating Expenses
OperatingExpenses
42206376 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2800825 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2727989 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-40898812 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10389832 usd
CY2024Q3 us-gaap Interest Income Operating
InterestIncomeOperating
220017 usd
CY2023Q3 us-gaap Interest Income Operating
InterestIncomeOperating
299506 usd
us-gaap Interest Income Operating
InterestIncomeOperating
619534 usd
us-gaap Interest Income Operating
InterestIncomeOperating
623971 usd
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
31608 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
25000 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
104403 usd
CY2024Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
-903609 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-1637895 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
-3327347 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-14438 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
86618 usd
us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-153442 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-534517 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
316676 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-906743 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2752415 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3335342 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2411313 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-41805555 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13142247 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
117000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3460342 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2450313 usd
us-gaap Net Income Loss
NetIncomeLoss
-41930555 usd
us-gaap Net Income Loss
NetIncomeLoss
-13259247 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.12
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124318056 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124318056 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
110360814 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
110360814 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
121944597 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
121944597 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108436146 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108436146 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-3460342 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2450313 usd
us-gaap Net Income Loss
NetIncomeLoss
-41930555 usd
us-gaap Net Income Loss
NetIncomeLoss
-13259247 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-25035 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10229 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-24795 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
31955 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
18236 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-54175 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
109046 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-72382 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6799 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-64404 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
84251 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-40427 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2514717 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41846304 usd
dei Amendment Flag
AmendmentFlag
false
CY2023Q3 us-gaap Gain Loss On Investments
GainLossOnInvestments
usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
CY2023Q2 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
usd
KOPN Increase Decrease In Accrued Litigation Damages
IncreaseDecreaseInAccruedLitigationDamages
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
usd
CY2024Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5710685 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1025000 usd
CY2024Q3 us-gaap Assets
Assets
70579507 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
651503 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1123220 usd
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
103181 usd
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6176 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
142899 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
125000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
125000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3467141 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13299674 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23990615 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
194190 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6227 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21335000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
21335000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-2628555 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
42897477 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1191257 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17750 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-8180379 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35926105 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
35926105 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
958335 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-64404 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
-2450313 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34369723 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34369723 usd
us-gaap Profit Loss
ProfitLoss
-41930555 usd
us-gaap Profit Loss
ProfitLoss
-13259247 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
470627 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
498188 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2624292 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2343782 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
125000 usd
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
117316 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
133002 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-27478 usd
KOPN Increase Decrease In Provision For Credit Losses
IncreaseDecreaseInProvisionForCreditLosses
24000 usd
KOPN Increase Decrease In Provision For Credit Losses
IncreaseDecreaseInProvisionForCreditLosses
726413 usd
KOPN Noncash Provision For Excess Inventory
NoncashProvisionForExcessInventory
1502468 usd
KOPN Noncash Provision For Excess Inventory
NoncashProvisionForExcessInventory
292405 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
1787852 usd
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
2887893 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-18878 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-514321 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-194890 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1031331 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2137460 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
5074336 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
1651437 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
390427 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2944672 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
426901 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
461365 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3106567 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1799444 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-671790 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-244188 usd
KOPN Increase Decrease In Accrued Litigation Damages
IncreaseDecreaseInAccruedLitigationDamages
24800000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12640553 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11791682 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
320873 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
478282 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
16875308 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
17624779 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
6915102 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
10374593 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
152971 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-14656 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10434050 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7713812 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7242581 usd
KOPN Issuance Of Common Stock And Prefunded Warrants Net Of Costs
IssuanceOfCommonStockAndPrefundedWarrantsNetOfCosts
25197050 usd
KOPN Issuance Of Common Stock And Prefunded Warrants Net Of Costs
IssuanceOfCommonStockAndPrefundedWarrantsNetOfCosts
21335000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32439631 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21335000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4880 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
11291 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9369908 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1840797 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6210685 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8258878 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15580593 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10099675 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_804_eus-gaap--BasisOfAccounting_zYVhkEldVUzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_82B_zIbZ3eNxyloj">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements of Kopin Corporation as of September 28, 2024 and for the three and nine month periods ended September 28, 2024 and September 30, 2023 are unaudited and include all adjustments, including normal recurring adjustments, that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2023. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The condensed consolidated financial statements for the three and nine month periods ended September 28, 2024 and September 30, 2023 include the accounts of Kopin Corporation and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company incurred a net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20230101__20231230_zfZjFnQevvP2">19.7 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million and net cash outflows from operations of $<span id="xdx_902_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20230101__20231230_zFoU58OWbqh6">15.3</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million for the fiscal year ended 2023. The Company incurred a net loss of $<span id="xdx_905_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20231231__20240928_zK0WzoSuN4X3">41.9</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million for the nine months ended September 28, 2024 and net cash outflows from operations of $<span id="xdx_90F_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20231231__20240928_z06MmOIlLTl3">12.6 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million. This net loss of $<span id="xdx_908_eus-gaap--NetIncomeLoss_iN_pn5n6_di_c20231231__20240928_zRsRSPqIg6Cc">41.9 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million includes an estimated $<span id="xdx_90B_ecustom--EstimatedPossibleDamagesAmount_pn5n6_c20231231__20240928_zT4g96jPqudg">24.8 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of possible damages related to a jury verdict which is explained below. In addition, the Company has experienced a significant decline in its cash and cash equivalents and marketable securities over the last several years, which was primarily a result of funding operating losses. As described in Note 14 Litigation, on April 22, 2024, a jury verdict was entered against the Company awarding approximately $<span id="xdx_90D_eus-gaap--LitigationSettlementLoss_pn5n6_c20240422__20240422_zwkOgtgP95La">5.1 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in damages as well as recommending $<span id="xdx_908_eus-gaap--PaymentsForLegalSettlements_pn5n6_c20240422__20240422_zraHXMKnPh4a">19.7 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in disgorgement and exemplary damages. On May 22, 2024, the Company filed its Motion for Judgment as a Matter of Law or in the alternative for a New Trial, as well as two submissions arguing that the disgorgement and exemplary damages should not be awarded. That same day, BlueRadios filed motions seeking a permanent injunction prohibiting Kopin from selling any products that incorporate BlueRadios’ trade secrets, over $<span id="xdx_907_eus-gaap--PrepaidInterest_iI_pn6n6_c20240522_zrtQW1AxwLCf">10 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in pre-judgment interest, and over $<span id="xdx_90B_eus-gaap--LegalFees_pn6n6_c20240522__20240522_zdD99kXnE9Lb">10 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million in attorneys’ fees and costs. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after briefing on the issues. Final briefings on the motions were made by the parties on October 29, 2024. The Company is also considering the appeal of any award in a final judgment. The Company had $<span id="xdx_903_eus-gaap--CashCashEquivalentsAndShortTermInvestments_iI_pn5n6_c20240928_zthdmDlnBvlk">37.3 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million of cash and cash equivalents, restricted cash, and marketable securities at September 28, 2024.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has historical and current negative cash flow from operations and limited liquidity resources. The Company’s current strategy is to continue to invest in its business and raise additional capital through financing activities that may include public offerings and private placements of its common stock, preferred stock offerings, collaborations and licensing arrangements and issuances of debt and convertible debt instruments. Until such time that additional capital can be raised, the Company plans to strategically manage its uncommitted spending, execute its priorities and implement cost saving measures to reduce research and development and general and administrative expenditures which could include minimizing staff costs. The Company may also sell assets and look at other strategic alternatives. There are inherent uncertainties associated with fundraising activities and activities to manage our uncommitted spending and the successful execution of these activities may not be within the Company’s control. There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company is unable to achieve positive cash flows and profitability in the foreseeable future, cannot successfully raise additional capital and implement its strategic plan, or the recommended disgorgement and exemplary damages are not significantly reduced or eliminated in the final order, the Company’s liquidity, financial condition and business prospects will be materially and adversely affected. There is substantial doubt about the Company’s ability to continue as a going concern.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-19700000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15300000 usd
us-gaap Net Income Loss
NetIncomeLoss
-41900000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-12600000 usd
us-gaap Net Income Loss
NetIncomeLoss
-41900000 usd
KOPN Estimated Possible Damages Amount
EstimatedPossibleDamagesAmount
24800000 usd
CY2024Q2 us-gaap Litigation Settlement Loss
LitigationSettlementLoss
5100000 usd
CY2024Q2 us-gaap Payments For Legal Settlements
PaymentsForLegalSettlements
19700000 usd
CY2024Q2 us-gaap Prepaid Interest
PrepaidInterest
10000000 usd
CY2024Q2 us-gaap Legal Fees
LegalFees
10000000 usd
CY2024Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
37300000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1100000 usd
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
22210410 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
12250204 usd
CY2024Q3 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
1833 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-58204 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
22212243 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
12192000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
21716258 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
495985 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
22212243 usd
CY2024Q3 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
35589043 usd
CY2023Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
21960127 usd
CY2024Q3 us-gaap Investments
Investments
5200000 usd
CY2023Q3 us-gaap Payments For Royalties
PaymentsForRoyalties
400000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3100000 usd
CY2023Q3 us-gaap Increase Decrease In Receivable For Investment Sold
IncreaseDecreaseInReceivableForInvestmentSold
2500000 usd
CY2024Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
700000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1100000 usd
CY2024Q2 us-gaap Increase Decrease In Receivable For Investment Sold
IncreaseDecreaseInReceivableForInvestmentSold
700000 usd
CY2024Q3 us-gaap Other Investments
OtherInvestments
2000000.0 usd
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10248935 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
10731036 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1015000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1025000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9233935 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9706036 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1025000 usd
us-gaap Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
24000 usd
us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
34000 usd
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
1015000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
3990155 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
4785197 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1728166 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2018421 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
837038 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
798188 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
6555359 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
7601806 usd
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5510914 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3948417 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5510914 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3948417 shares
CY2024Q3 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
37550000 shares
CY2024Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
3080000 shares
CY2024Q1 KOPN Gross Proceeds From Registered Sale Equity Securities
GrossProceedsFromRegisteredSaleEquitySecurities
7466755 usd
CY2024Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.42
CY2023Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
17000000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1931767 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
4226320 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
399644 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.50
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
247529 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.00
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
5510914 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
1.30
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1212946 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
958335 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2624292 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2343782 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1212946 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
958335 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2624292 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2343782 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4200000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
us-gaap Extended Product Warranty Description
ExtendedProductWarrantyDescription
The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty.
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2160000 usd
us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
700000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
185000 usd
CY2024Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2675000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 usd
CY2024Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 usd
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
100000 usd
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
122700000 usd
KOPN Operating Loss Carryforwards Expiring Date
OperatingLossCarryforwardsExpiringDate
expiring 2024 through 2038
CY2024Q3 KOPN Operating Loss Carryforwards Unlimited
OperatingLossCarryforwardsUnlimited
107800000 usd
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
8274538 usd
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3409809 usd
us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueModificationOfContract
4864729 usd
CY2024Q3 KOPN Percentage Of Change In Contract Assets Current
PercentageOfChangeInContractAssetsCurrent
1.43 pure
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
268468 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
916826 usd
KOPN Contract With Customer Liability And Billings In Revenue Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityAndBillingsInRevenueCumulativeCatchUpAdjustmentToRevenueModificationOfContract
648358 usd
CY2024Q3 KOPN Percentage Contract Liabilities And Billings In Excess Of Revenue Earned
PercentageContractLiabilitiesAndBillingsInExcessOfRevenueEarned
-0.71 pure
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
23198 usd
us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
23198 usd
CY2024Q3 KOPN Percentage Of Change In Contract Liabilitiesnoncurrent
PercentageOfChangeInContractLiabilitiesnoncurrent
-1 pure
CY2024Q3 KOPN Net Contract Assets Liabilities
NetContractAssetsLiabilities
8006070 usd
CY2023Q4 KOPN Net Contract Assets Liabilities
NetContractAssetsLiabilities
2469785 usd
KOPN Contract With Customer Assets Liability Cumulative Catch Up Adjustment To Revenue Modification Of Contract
ContractWithCustomerAssetsLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract
5536285 usd
CY2024Q3 KOPN Percentage Of Change In Net Contract Assets Liabilities
PercentageOfChangeInNetContractAssetsLiabilities
2.24 pure
CY2024Q3 KOPN Net Contract Assets
NetContractAssets
5500000 usd
CY2024Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000 usd
CY2023Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
100000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
700000 usd
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
25400000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
218348 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
216119 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
651718 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
648545 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
212013 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
766014 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
732610 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
669255 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
201333 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2581225 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
293289 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2287936 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
653546 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1634390 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2287936 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
649276 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
741757 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0680 pure
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0606 pure
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y4M17D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y1M9D
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
4322000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
4668000 usd
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
4322000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
4668000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13320000 usd
CY2024Q3 KOPN Percentage Of Total Revenue
PercentageOfTotalRevenue
1 pure
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10598000 usd
CY2023Q3 KOPN Percentage Of Total Revenue
PercentageOfTotalRevenue
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35689000 usd
KOPN Percentage Of Total Revenue
PercentageOfTotalRevenue
1 pure
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31817000 usd
KOPN Percentage Of Total Revenue
PercentageOfTotalRevenue
1 pure
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13320000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10598000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35689000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31817000 usd
CY2024Q2 us-gaap Loss Contingency Damages Sought
LossContingencyDamagesSought
On Monday, April 22, 2024, after a four week trial, a jury verdict was entered finding for BlueRadios and awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after post-trial briefing.
CY2024Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
10000000 usd
CY2024Q2 us-gaap Payments For Fees
PaymentsForFees
10000000 usd
us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
5100000 usd
KOPN Loss Contingency Exemplary Damages Sought Value
LossContingencyExemplaryDamagesSoughtValue
19700000 usd
CY2024Q3 us-gaap Revenues
Revenues
205984 usd
CY2024Q3 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
6650 usd
CY2023Q3 us-gaap Revenues
Revenues
485338 usd
CY2023Q3 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
208933 usd
us-gaap Revenues
Revenues
647617 usd
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
193305 usd
us-gaap Revenues
Revenues
1757739 usd
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
416988 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
230105 usd
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
144915 usd
CY2023Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
97600 usd

Files In Submission

Name View Source Status
0001493152-24-044738-index-headers.html Edgar Link pending
0001493152-24-044738-index.html Edgar Link pending
0001493152-24-044738.txt Edgar Link pending
0001493152-24-044738-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
kopn-20240928.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
kopn-20240928_cal.xml Edgar Link unprocessable
kopn-20240928_def.xml Edgar Link unprocessable
kopn-20240928_lab.xml Edgar Link unprocessable
kopn-20240928_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable